Journal of the European Academy of Dermatology and Venereology

Article	Citations
Editor's Picks	274
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser	187
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin	177
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic	160
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	155
Are non‐fungible tokens the barrier to realizing the Dermoverse?	138
Announcement	119
	88
Announcement	85
Editor's Picks January 2024	81
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	77
Announcement	74
Issue Information	69
Peer review, scientific publishing and the law of reciprocity	69
	68
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti	64
Efficacy of imiquimod in the management of lentigo maligna	61
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	60
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	58
Juvenile localized scleroderma: A single‐centre experience from India	58
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	56
	54
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	53
Issue Information	52
Announcement	50

	50
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use	48
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization	48
Announcement	47
Dalbavancin for the treatment of severe hidradenitis suppurativa	46
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	43
The chicken or the egg of lymphopenia in atopic eczema	43
A case of eruptive halo nevi following COVID‐19	43
The future of digital pills and their potential use in dermatological clinical trials	42
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–2019	42
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination	41
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study	41
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	40
Flagellate purpura associated with COVID‐19 vaccination	40
Pharmacovigilance: The responsibility of all	40
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study	39
Louis Adolphus Duhring: An enduring legacy	39
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study	39
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	38
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century	38
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.	38
Dupilumab for the treatment of refractory allergic contact dermatitis from rubber/latex concomitant with atopic dermatitis	38
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study	38
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	37
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	37
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	37
Clinical and molecular diagnosis of genodermatoses: Review and perspectives	36
A new era for alopecia areata: New treatments and improved knowledge of the condition	36
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	36
Rosacea and upper gastrointestinal disorders: a case‐control study from a large, urban academic centre	36
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	36
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	34
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	34
Hand–foot syndrome like eruption following mRNA COVID‐19 vaccine	34
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	34
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	34
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	33
Editor’s Picks June 2025	33
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study	33
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies	33
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors	33
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	33
Impact of menopause on the skin…information still insufficient	33
Educational, labour market and relationship outcomes in people with acne	33
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	32
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma	32
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	32
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort	32
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	32
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab	32

Assessing the efficacy of selective JAK inhibitors for alopecia areata with a patient‐centered approach	31
Real‐life efficacy and safety of upadacitinib in adolescents with moderate‐to‐severe atopic dermatitis unresponsive to dupilumab: A case series	31
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations	31
Systemic neurokinin‐1 receptor antagonists mitigate chronic pruritus: A systematic review and meta‐analysis	31
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US	31
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment	30
Urinary incontinence and female genital lichen sclerosus	30
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024	30
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin	30
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab	29
Two cases of cerebrovascular accidents following the induction dose of risankizumab	29
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	29
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study	29
Application of integrated skincare in medical aesthetics: A literature review	29
Pityriasis lichenoides et varioliformis acuta after SARS‐CoV‐2 infection and relapse after vaccination	28
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	28
Chat GPT in dermatology: Progressive or problematic?	28
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity	28
Biomarkers in rosacea: A systematic review	28
Advances in biologic therapy of psoriasis	28
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer	28
Pioneers in Dermatology and Venereology: an interview with Professor Francisco Miguel Camacho Martinez	28
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review	28
	27
Commentary to ‘Development of a patient‐reported experience measure for chronic inflammatory skin diseases’ by E. Van den Steen et al.	27
Announcement	27
	27
Issue Information	27
	27
Announcement	27
Announcement	27
	26
Hair transplantation in folliculitis decalvans: Outcome description in a multicentre series of 11 patients	26
Response to ‘Dupilumab: No elevated maternal risks in propensity‐matched cohort’ by Preuß et al.	26
Comparison of the burden of pruritus and pain: Analysis of survey data from 4018 subjects	26
Announcement	26
Diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics	26
Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study	26
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients	26
New regulation of medical devices in the EU: impact in dermatology	26
Erectile dysfunction in patients with seborrhoeic dermatitis	25
A special thank you to our reviewers!	25
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation	25
Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction	25
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch	25
Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients	25
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single‐centre experience	25
	25
Beyond the surface: Integrating sex and gender in dermatologic therapy	24
Dermatitis herpetiformis triggered by iodine contrast media	24
Is risankizumab as needed administration a good option for patients with plaque psoriasis?	24
	24
Stevens‐Johnson syndrome induced by Vaxvetria (AZD1222) COVID‐19 vaccine	24
Pioneers in Dermatology and Venereology: an interview with Professor Jens‐Michael Schröder	24
Sensitivity of clinician‐assessed efficacy outcome measurement instruments in trials of topical therapies for atopic dermatitis: a systematic review and meta‐analysis	24
Rifampicin and clindamycin for epidermal growth factor receptor inhibitor‐related acneiform rash	23
Basal cell carcinoma on the ventral site of the finger with an intronic deletion of SUFU gene	23
Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicen	23
Evidence for no genetic causal association between skin response to sun exposure and systemic lupus erythematosus: A Mendelian randomization study in Europeans and East Asians	23
Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients	23
Chronic urticaria – From ‘Cinderella’ to a ‘Rock star’ in 30 years	23
Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”	23
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID‐19 pandemic in a reference centre in Mexico	23
Beta‐blockers efficacy and safety in the treatment of PHACE syndrome: A systematic review	23
Upadacitinib in dermatology: ‘Killing’ several diseases with one stone	23
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin	23
Incidence and remission rates of self‐reported hidradenitis suppurativa ‐ A prospective cohort study conducted in Danish blood donors	23
Evidence for differing roles of CD11c+CD163+ and CD11c−CD163+ cells in intracellular pigment storing in tattoos and stasis	23
Serial dermoscopic monitoring of subungual scabies mites in an infant with crusted scabies	22
Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study	22
Deciphering differential response to NB‐UVB: The hair matters	22
Female genital mucosal lesions associated with COVID‐19 vaccination: A brief review of the literature	22
Chronic pruritus in multiple sclerosis and clinical correlates	22
Drug reaction with eosinophilia and systemic symptoms in a 10‐year‐old boy sparing lichen planus lesions: an example of reverse isotopic response	22
Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis	22
Dermoscopic image colour correction based on gamma correction and multi‐scale image fusion	22
Non‐coeliac gluten sensitivity: an underdiagnosed condition in dermatology?	22
Are the chilblain‐like lesions observed during the COVID‐19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta‐analysis	22
Oral and genital suction purpura	22
Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patients	22

Morphoea en coup de sabre with Adie's pupil: An exceptional association	22
Penile nodules as a manifestation of lymphogranuloma venereum: an underrecognized form	22
Effects of bariatric surgery on severe suppurative hidradenitis: Results of a nationwide administrative data study in France	22
High‐dose intravenous immunoglobulin co‐treatment prolongs time‐to‐treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study	22
Burnout among French dermatologists: A national study	21
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience	21
Severity strata and minimally important differences of CompAQ and Skindex‐16 for patients with acne	21
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study	21
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV‐2 vaccine—A case review	21
Long‐term effects of the COVID‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics	21
High‐frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta‐analysis	21
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study	21
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study	21
Scabies revisited in the COVID‐19 era	21
A cross‐sectional study of dermatologists' attitudes towards COVID‐19 vaccination in patients with immunobullous diseases	21
Outcome and long‐term treatment protocol for topical tacrolimus in oral lichen planus	21
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine	21
Premature skin ageing signs due to androgen deprivation therapy	20
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis	20
Ambassadors in Dermatology and Venereology: An interview with Professor Andreas Katsambas	20
Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5‐year randomized controlled trial with 12‐month follow‐up	20
Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide‐scale cohort study	20
From COVID‐19 to war – life of a dermatological journal in times of crisis	20
Paediatric mycosis fungoides – characteristics, management and outcomes with particular focus on the folliculotropic variant	20
Pioneers in Dermatology and Venereology: An interview with Professor Johannes Ring	20
Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients	20
2021 European guideline on the management of Mycoplasma genitalium infections	20
Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial	20
Announcement	20
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry	19
Alopecia universalis improvement following risankizumab in a psoriasis patient	19
Analysis of the structure and function of the epidermal barrier in patients with ichthyoses—clinical and electron microscopical investigations	19
Health‐related quality of life during different stages of decongestive therapy on patients with lymphoedema of the legs	19
Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’	19
Thirty years of promoting sun safety in France: The messages are heard but not followed!	19
Erythema multiforme after SARS‐CoV‐2 vaccine	19
False negative RPR test with prozone phenomenon in an HIV‐negative man with secondary syphilis	19
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study	19
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group	19
A 5‐year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension	19
A novel and effective therapy for Zoon balanitis: Topical crisaborole 2% ointment	19
Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?	19
Delayed hypersensitivity of hyaluronidase: a case report	19
The watch sign: an atypical clinical finding of frontal fibrosing alopecia in two male patients	19
Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study	19
Cryosurgery versus curettage for intraepidermal carcinoma: A randomized controlled trial	19
Racial representation in dermatology clinical trials, a Canadian perspective	19
A rare case of agminated juvenile Xanthogranuloma: Clinical and dermatoscopic evolution	19
Dupilumab treatment for severe atopic dermatitis in children and SARS‐CoV‐2 infection: A combination of triggers for psoriasis	18
	18
Concordance of in vivo reflectance confocal microscopy and horizontal‐sectioning histology in skin tumours	18
Study on hair root lipids of female androgenetic alopecia based on UPLC‐Q‐TOF/MS results	18
Improvement of redness and hyperkeratosis in a case of Nagashima‐type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis	18
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta‐analysis of phase III trials	18
Issue Information	18
The tumour triangle – A symbol‐based mnemonic for teaching important clinical characteristics of skin cancer	18
Fears, concerns and expectations in dermatologic emergencies: A qualitative and descriptive study in a tertiary hospital	18
Nonsense mutations in KRT1 caused recessive epidermolytic palmoplantar keratoderma with knuckle pads	18
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study	18
Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain‐of‐function mutation	18
Store‐and‐forward mobile application as an accessible method of study participant assessment	18
Culture‐based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients	18
Neuropathy as an early warning sign of desmoplastic neurotropic melanoma of the head	18
Sensitive skin: A relevant syndrome, be aware	17
Infantile scabies misdiagnosed and treated as Langerhans cell histiocytosis: A case report	17
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature	17
Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients	17
Tinea nigra with dermoscopic diagnosis: First autochthonous case in Italy?	17
Reply to ‘Nail psoriasis: A rare mRNA COVID‐19 vaccine reaction’ by Lamberti A et al.	17
A deep‐learning algorithm to localize basal cell carcinoma foci on Mohs surgery frozen sections	17
Announcement	17
Purtscher‐like retinopathy after hyaluronic filler injection for facial augmentation	17
A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERASstudy)	17
Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A post‐hoc analysis of PSO‐LON	17
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo	17
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry	17
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial	17
Advances in image‐based diagnosis of nail disorders	17
Hidradenitis suppurativa: A prospective epidemiologic study in Albania	17
Correction to ‘Classification of psychodermatological disorders: Proposal of a new international classification’	17
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab	17
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb ran	17
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study	17
Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning	16
Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study	16
Probing into functional decline among bullous pemphigoid patients	16
Announcement	16
	16
Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center	16
Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?—Insights from an international population‐based study	16
Announcement	16
Forthcoming EADV Events	16
Lentigo maligna: A retrospective analysis of 50 cases treated with imiquimod monitored with non‐invasive reflectance confocal microscopy	16
Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023	16
Insights into AI and facial ageing	16